We have analyzed the role of chitin, a cellwall polysaccharide, in the virulence of Candida albicans. Mutants with a 5-fold reduction in chitin were obtained in two ways: (i) by selecting mutants resistant to Calcofluor, a fluorescent dye that binds to chitin and inhibits growth, and(ii) by disrupting CHS3, the C. albicans homolog of CSD2/ CALJ/DITIOI/KT12, a Saccharomyces cereviswe gene required for synthesis of '90% of the cell-wall chitin. A key step in the development of an antifungal drug is the determination of its efficacy. For practical reasons, much of the initial testing is done in culture (in vitro), where the test conditions differ markedly from the conditions encountered by a fungal pathogen during infection (in vivo). The limited ability of in vitro testing to accurately predict in vivo efficacy is illustrated by the azoles, which are highly effective in vivo despite modest fungicidal activity in vitro (1). Thus, it is possible that some fungal components are required for pathogenicity in vivo but not for growth in vitro. Possible virulence determinants include factors required for recognition and invasion of the host and for protection against host defense systems. Because the cell wall is involved in these processesthe wall protects the fungal cell from external injury and cell-wall components mediate adherence (2-4) and immune response (5-8)-changes in cell-wall structure and/or composition may affect virulence.We have begun to investigate the role of the cell-wall polysaccharide chitin in the virulence of Candida albicans. Chitin is found in all true fungi; therefore agents that inhibit chitin synthesis are potential broad-spectrum antifungal drugs. In the past decade, many of the genes involved in chitin synthesis have been isolated in Saccharomyces cerevisiae, and, more recently, the homologs of these genes have been identified in C. albicans (9-11).In S. cerevisiae, three chitin synthases have been detected (for review, see refs. 12 and 13). One of them, chitin synthase III, makes 90% of the cell-wall chitin. At least three genes, CSD2/CALl/DIT101/KT12, CSD4/CAL2, and CAL3, are required for this activity. Mutants lacking this enzyme are chitin-deficient and, consequently, are resistant to Calcofluor, a fluorescent dye that binds to chitin and inhibits growth by disrupting microfibril assembly (14, 15).Like S. cerevisiae, C. albicans has at least three chitin synthases (9-11). Recently, the C. albicans homolog of CSD2, designated CHS3, was cloned and sequenced (11). By analogy to S. cerevisiae, C. albicans CHS3 mutants should be chitindeficient and Calcofluor-resistant. In the present report, we show that chitin-deficient mutants of C. albicans obtained by two methods are significantly less virulent than the wild-type strain. . Media were supplemented with uridine at 0.1 mg/ml as required. Agar (2%, Difco) was added for solid media. Urdauxotrophs were selected on medium containing 5-fluoroorotic acid (5-FOA) as described (16). Germ-tube formation was induced in 20% fetal bovine serum ...